• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DU Guanhua,LYU Yang.Polymorphism of drugs:the main factor affecting the drug quality[J].Journal Of Pharmaceutical Research,2017,36(6):311-314,336[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3891times   Download 3097次 QR Code for this article
Scan with your phone!
药品质量的影响因素—化学固体药物的晶型研究
杜冠华1,吕扬2
Font:Larger+|Default|Smaller-
(1.北京市药物靶点研究与药物筛选重点实验室,中国医学科学院北京协和医学院药物研究所,北京 100050;2.北京市药物晶型研究重点实验室,中国医学科学院北京协和医学院药物研究所,北京 100050)
摘要:
化学固体药物的质量直接关系到药物治疗疾病的效果,影响药物质量的因素来自于药物原料,药物辅料以及制备工艺等多方面,需要经过研究确定能够保证药物疗效的质量标准。除此之外,药物晶型是影响药物疗效的重要影响因素,这种晶型包括原料药的晶型,辅料的晶型,也包括原料药在制剂这一复杂体系中的晶型状态。优势药物晶型是指在同一药物的多种晶型中,可以实现最贱临床治疗效果的晶型,研究和控制药物晶型,可以提高药物的质量,保证药物的临床治疗作用。本文讨论了药物晶型的发现、检测、评价和应用的要求,为晶型药物的研究提供信息参考。
关键词:  化学固体药物  晶型  药品质量  影响因素
DOI:10.13506/j.cnki.jpr.2017.06.001
基金项目:国家科技重大专项“重大新药创制”项目(No.2013ZX09508104、No.2013ZX09402203);国家科技部重点研发计划(No.2016YFC1000905)
Polymorphism of drugs:the main factor affecting the drug quality
DU Guanhua1,LYU Yang2
(1.Beinjing Key Laboratory of Drug Target Research and Drug Screening,Institute of Materia Medica,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100050,China;2.Beijing Key Laboratory of Polymorphic Drugs, Institute of Materia Medica,Chinese Academy of Medical Science and Peking Union Medical College,Beijing 100050,China)
Abstract:
The quality of the small molecule drugs is an important and complex problems which related to clinical therapeutic effects.There are many different factors influencing the quality of drugs include API,excipients and preparation technology related factors.Except these factors,the crystal form of API is the core factors which closely related with bioavailability of drugs.Appliation and controlling the Optimal Drug Crystal form (ODC) of API in solid pharmaceutical preparations are the key procedures for drug quantity.This article discussed the discovery,detection,evaluation and application requirements of drug crystal,to provide information for the study of crysalline drugs.
Key words:  Chemical solid medicine  Crystal form  Drug quantity  Influencing factors
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.